These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 8407271
1. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein. Hussein O, Brook GJ, Aviram M. Isr J Med Sci; 1993 Aug; 29(8):453-9. PubMed ID: 8407271 [Abstract] [Full Text] [Related]
2. Serotonin increases macrophage uptake of oxidized low density lipoprotein. Aviram M, Fuhrman B, Maor I, Brook GJ. Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):55-61. PubMed ID: 1581411 [Abstract] [Full Text] [Related]
4. Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway. Keidar S, Attias J. Biochem Biophys Res Commun; 1997 Oct 09; 239(1):63-7. PubMed ID: 9345270 [Abstract] [Full Text] [Related]
9. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis. Seike M, Ikeda M, Matsumoto M, Hamada R, Takeya M, Kodama H. J Dermatol Sci; 2006 Mar 09; 41(3):197-204. PubMed ID: 16356687 [Abstract] [Full Text] [Related]
13. Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein. Fuhrman B, Brook GJ, Aviram M. Atherosclerosis; 1991 Aug 15; 89(2-3):163-73. PubMed ID: 1793444 [Abstract] [Full Text] [Related]
14. Role of platelet secretory products in modified lipoprotein metabolism in macrophages. Hayashi T, Naito M, Kuzuya M, Funaki C, Tateishi T, Asai K, Kuzuya F. Artery; 1989 Aug 15; 16(5):248-62. PubMed ID: 2764730 [Abstract] [Full Text] [Related]
15. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Kamanna VS, Pai R, Roh DD, Kirschenbaum MA. Lab Invest; 1996 Jun 15; 74(6):1067-79. PubMed ID: 8667611 [Abstract] [Full Text] [Related]
16. Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate. A possible role for phosphatidic acid. Aviram M, Maor I. J Clin Invest; 1993 May 15; 91(5):1942-52. PubMed ID: 8486764 [Abstract] [Full Text] [Related]
17. Platelet secreted lipoprotein-like particle is taken up by the macrophage scavenger receptor and enhances cellular cholesterol accumulation. Maor I, Brook GJ, Aviram M. Atherosclerosis; 1991 Jun 15; 88(2-3):163-74. PubMed ID: 1892483 [Abstract] [Full Text] [Related]
18. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients. Hayek T, Aviram M, Heinrich R, Sakhnini E, Keidar S. Biochem Biophys Res Commun; 2000 Jul 05; 273(2):417-20. PubMed ID: 10873620 [Abstract] [Full Text] [Related]
19. Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity. Aviram M, Dankner G, Brook JG. Arteriosclerosis; 1990 Jul 05; 10(4):559-63. PubMed ID: 2369366 [Abstract] [Full Text] [Related]
20. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Boullier A, Li Y, Quehenberger O, Palinski W, Tabas I, Witztum JL, Miller YI. Arterioscler Thromb Vasc Biol; 2006 May 05; 26(5):1169-76. PubMed ID: 16484596 [Abstract] [Full Text] [Related] Page: [Next] [New Search]